BOFAS News & Events

This pages lists all the latest news and upcoming events.

 

To access 'Foot Print' (the BOFAS Bulletin) please click here (members only)

 

Latest News

2021

BOFAS Annual Meeting Abstracts from 2021

123456789

 

BOFAS Hosted Events

Courses organised by BOFAS
 

 

BOFAS Affiliated Courses

Courses by organisations with an affiliation to BOFAS
 

Other External Events / Courses

Independant courses organised by other organisations not directly affiliated with BOFAS, but which BOFAS members may find of value.
 
Togay Koç
/ Categories: Abstracts, 2016, Poster

Silastic arthroplasty versus 1st metatarsophalangeal joint arthrodesis: a prospective comparative series

S.E. Eastwood, A. Kingman, S. Asaad, J. Coorsh, R. Kakwani, A.N. Murty, D. Townshend

Introduction: Both 1st MTPJ arthrodesis and silastic arthroplasty have been shown to provide good long-term outcomes for end-stage hallux rigidus. Novel implants are compared against arthrodesis as a historical gold standard. Although there is good evidence to demonstrate long term survival from the established Swanson silastic arthroplasty there are no published studies comparing this to arthrodesis. We present a comparison of outcomes in patients who had these procedures performed after a shared decision-making process.

Methods: Consecutive patients who received 1st MTPJ arthrodesis or silastic arthroplasty for hallux rigidus between June 2014 and November 2015 were included. Demographics, complications and prospectively collected pre-operative and 6-months post-operative PROMS (MOXFQ and VAS) were reviewed.

Results: 61 patients received silastic arthroplasty (52 female, mean age 63 years) and 61 patients received arthrodesis (25 female, mean age 60 years). Complete PROMS data was available for 53% of patients. There was a significant improvement in MOXFQ and VAS following both silastic arthroplasty (MOXFQ mean change 18, p=0.005; VAS mean change 24, p=0.0004) and arthrodesis (MOXFQ mean change 38, p< 0.0001; VAS mean change 44, p< 0.0001). There was a significant difference in mean improvement of both MOXFQ and VAS in favour of arthrodesis (MOXFQ p=0.0004, VAS p=0.002). There was 1 post-operative infection and 1 reoperation (conversion to fusion) in the silastic arthroplasty group, and 1 post-operative infection and 6 reoperations (4 removal of prominent metalwork, 2 revision fusions) in the arthrodesis group.

Conclusion: Both silastic arthroplasty and arthrodesis have shown a significant improvement in pain and function with low complication rates. Patients may choose arthroplasty over arthrodesis to maintain motion. In these cohorts, arthrodesis showed a greater improvement over silastic arthroplasty in patient reported outcomes but a higher reoperation rate and this should be considered in the shared decision-making process.

 

Print
847